Malaria Author: Rick M. Fairhurst, MD, PhD; Thomas E. Wellems, MD, PhD
Module updated - 2009-11-19
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools
References
1. 3Kain KC, Keystone JS. Malaria in travelers. Epidemiology, disease, and prevention. Infect Dis Clin North Am. 1998;12:267-84. (PMID: 9658245)
2. 2Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Epidemiology of drug-resistant malaria. Lancet Infect Dis. 2002;2:209-18. (PMID: 11937421)
3. 2al Arishi HM, el Awad Ahmed F, al Bishi LA. Chloroquine-resistant Plasmodium falciparum malaria among children seen in a regional hospital, Tabuk, Saudi Arabia. Trans R Soc Trop Med Hyg. 2001;95:439-40. (PMID: 11579892)
4. 2Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Luxemburger C, Webster HK, Edstein M, et al. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet. 1991;337:1140-3. (PMID: 1674024)
5. 2Chia JK, Nakata MM, Co S. Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon. J Infect Dis. 1992;165:599-600. (PMID: 1538173)
6. 2Murphy GS, Basri H, Purnomo, Andersen EM, Bangs MJ, Mount DL, et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet. 1993;341:96-100. (PMID: 8093414)
7. 2Baird JK, Wiady I, Fryauff DJ, Sutanihardja MA, Leksana B, Widjaya H, et al. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am J Trop Med Hyg. 1997;56:627-31. (PMID: 9230793)
8. 2Garavelli PL, Corti E. Chloroquine resistance in Plasmodium vivax: the first case in Brazil. Trans R Soc Trop Med Hyg. 1992;86:128. (PMID: 1440766)
9. 2Barrett JP, Behrens RH. Prophylaxis failure against vivax malaria in Guyana, South America. J Travel Med. 1996;3:60-1. (PMID: 9815425)
10. 2Soto J, Toledo J, Gutierrez P, Luzz M, Llinas N, Cedeno N, et al. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg. 2001;65:90-3. (PMID: 11508397)
11. 2Garg M, Gopinathan N, Bodhe P, Kshirsagar NA. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans R Soc Trop Med Hyg. 1995;89:656-7. (PMID: 8594687)
12. 2Marlar-Than, Myat-Phone-Kyaw, Aye-Yu-Soe, Khaing-Khaing-Gyi, Ma-Sabai, Myint-Oo. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans R Soc Trop Med Hyg. 1995;89:307-8. (PMID: 7660445)
13. 2Maguire JD, Sumawinata IW, Masbar S, Laksana B, Prodjodipuro P, Susanti I, et al. Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia. Lancet. 2002;360:58-60. (PMID: 12114045)
14. 2Bacaner N, Stauffer B, Boulware DR, Walker PF, Keystone JS. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA. 2004;291:2856-64. (PMID: 15199037)
15. 1Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, et al. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Malarone International Study Team. Clin Infect Dis. 2001;33:1015-21. (PMID: 11528574)
16. 1Sukwa TY, Mulenga M, Chisdaka N, Roskell NS, Scott TR. A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia. Am J Trop Med Hyg. 1999;60:521-5. (PMID: 10348223)
17. 1Shanks GD, Gordon DM, Klotz FW, Aleman GM, Oloo AJ, Sadie D, et al. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria. Clin Infect Dis. 1998;27:494-9. (PMID: 9770146)
18. 1Croft AM, Garner P. Mefloquine for preventing malaria in non-immune adult travellers. Cochrane Database Syst Rev. 2000;4:CD000138. (PMID: 11034675)
19. 1Ohrt C, Richie TL, Widjaja H, Shanks GD, Fitriadi J, Fryauff DJ, et al. Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1997;126:963-72. [Full Text] (PMID: 9182474)
20. 1Taylor WR, Richie TL, Fryauff DJ, Picarima H, Ohrt C, Tang D, et al. Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clin Infect Dis. 1999;28:74-81. (PMID: 10028075)
21. 3Malaria deaths following inappropriate malaria chemoprophylaxis—United States, 2001. MMWR Morb Mortal Wkly Rep. 2001;50:597-9. (PMID: 11476528)
22. 3Shah S, Filler S, Causer LM, Rowe AK, Bloland PB, Barber AM, et al. Malaria surveillance—United States, 2002. MMWR Surveill Summ. 2004;53:21-34. (PMID: 15123983)
23. 2Muehlberger N, Jelinek T, Schlipkoeter U, von Sonnenburg F, Nothdurft HD. Effectiveness of chemoprophylaxis and other determinants of malaria in travellers to Kenya. Trop Med Int Health. 1998;3:357-63. (PMID: 9623940)
24. 2Greenberg AE, Lobel HO. Mortality from Plasmodium falciparum malaria in travelers from the United States, 1959 to 1987. Ann Intern Med. 1990;113:326-7. (PMID: 2197915)
25. 3Prevention of malaria. Med Lett. 2005;47(1223):100-3.
26. 3Newton P, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, et al. Fake artesunate in southeast Asia. Lancet. 2001;357:1948-50. (PMID: 11425421)
27. 3Bjorkman A, Phillips-Howard PA. Adverse reactions to sulfa drugs: implications for malaria chemotherapy. Bull World Health Organ. 1991;69:297-304. (PMID: 1893504)
28. 3Phillips-Howard PA, West LJ. Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. J R Soc Med. 1990;83:82-5. (PMID: 2138674)
29. 2Hatton CS, Peto TE, Bunch C, Pasvol G, Russell SJ, Singer CR, et al. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet. 1986;1:411-4. (PMID: 2868340)
30. 3Advice for travelers. Med Lett. 2009;7(87):83.
31. 2Schoepke A, Steffen R, Gratz N. Effectiveness of personal protection measures against mosquito bites for malaria prophylaxis in travelers. J Travel Med. 1998;5:188-92. (PMID: 9876193)
32. 1Lengeler C. Insecticide-treated bednets and curtains for preventing malaria. Cochrane Database Syst Rev. 2000;2:CD000363. (PMID: 10796535)
33. 1Phillips-Howard PA, Nahlen BL, Alaii JA, ter Kuile FO, Gimnig JE, Terlouw DJ, et al. The efficacy of permethrin-treated bed nets on child mortality and morbidity in western Kenya I. Development of infrastructure and description of study site. Am J Trop Med Hyg. 2003;68:3-9. (PMID: 12749479)
34. 1Rowland M, Freeman T, Downey G, Hadi A, Saeed M. DEET mosquito repellent sold through social marketing provides personal protection against malaria in an area of all-night mosquito biting and partial coverage of insecticide-treated nets: a case-control study of effectiveness. Trop Med Int Health. 2004;9:343-50. (PMID: 14996363)
35. 1Rowland M, Downey G, Rab A, Freeman T, Mohammad N, Rehman H, et al. DEET mosquito repellent provides personal protection against malaria: a household randomized trial in an Afghan refugee camp in Pakistan. Trop Med Int Health. 2004;9:335-42. (PMID: 14996362)
36. 2Lillie TH, Schreck CE, Rahe AJ. Effectiveness of personal protection against mosquitoes in Alaska. J Med Entomol. 1988;25:475-8. (PMID: 2905009)
37. 2Alexander B, Cadena H, Usma MC, Rojas CA. Laboratory and field evaluations of a repellent soap containing diethyl toluamide (DEET) and permethrin against phlebotomine sand flies (Diptera: Psychodidae) in Valle del Cauca, Colombia. Am J Trop Med Hyg. 1995;52:169-73. (PMID: 7872447)
38. 2Lobel HO, Baker MA, Gras FA, Stennies GM, Meerburg P, Hiemstra E, et al. Use of malaria prevention measures by North American and European travelers to East Africa. J Travel Med. 2001;8:167-72. (PMID: 11703900)
39. 1Fradin MS. Mosquitoes and mosquito repellents: a clinician's guide. Ann Intern Med. 1998;128:931-40. [Full Text] (PMID: 9634433)
40. 1Nevill CG, Some ES, Mung'ala VO, Mutemi W, New L, Marsh K, et al. Insecticide-treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan coast. Trop Med Int Health. 1996;1:139-46. (PMID: 8665377)
41. 2D'Ortenzio E, Godineau N, Fontanet A, Houze S, Bouchaud O, Matheron S, et al. Prolonged Plasmodium falciparum infection in immigrants, Paris. Emerg Infect Dis. 2008;14:323-6. (PMID: 18258132)
42. 3Redd SC, Kazembe PN, Luby SP, Nwanyanwu O, Hightower AW, Ziba C, et al. Clinical algorithm for treatment of Plasmodium falciparum malaria in children. Lancet. 1996;347:223-7. (PMID: 8551881)
43. 2Hu KK, Maung C, Katz DL. Clinical diagnosis of malaria on the Thai-Myanmar border. Yale J Biol Med. 2001;74:303-08. (PMID: 11769335)
44. 2van der Hoek W, Premasiri DA, Wickremasinghe AR. Clinical diagnosis of uncomplicated malaria in Sri Lanka. Southeast Asian J Trop Med Public Health. 1998;29:242-5. (PMID: 9886105)
45. 3Newman RD, Parise ME, Barber AM, Steketee RW. Malaria-related deaths among U.S. travelers, 1963-2001. Ann Intern Med. 2004;141:547-55. (PMID: 15466772) [Full Text]
46. 2Jelinek T, Nothdurft HD, Loscher T. Malaria in nonimmune travelers: A synopsis of history, symptoms, and treatment in 160 patients. J Travel Med. 1994;1:199-202. (PMID: 9815339)
47. 2Mühlberger N, Jelinek T, Gascon J, Probst M, Zoller T, Schunk M, et al. Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J. 2004;3:5. (PMID: 15003128)
48. 2Schwartz E, Parise M, Kozarsky P, Cetron M. Delayed onset of malaria—implications for chemoprophylaxis in travelers. N Engl J Med. 2003;349:1510-6. (PMID: 14561793)
49. 2Moore DA, Grant AD, Armstrong M, Stümpfle R, Behrens RH. Risk factors for malaria in UK travellers. Trans R Soc Trop Med Hyg. 2004;98:55-63. (PMID: 14702838)
50. 2Vinetz JM, Li J, McCutchan TF, Kaslow DC. Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. N Engl J Med. 1998;338:367-71. (PMID: 9449730)
51. 2Chadee DD, Tilluckdharry CC, Maharaj P, Sinanan C. Reactivation of Plasmodium malariae infection in a Trinidadian man after neurosurgery. N Engl J Med. 2000;342:1924. (PMID: 10877649)
52. 2Tsuchida H, Yamaguchi K, Yamamoto S, Ebisawa I. Quartan malaria following splenectomy 36 years after infection. Am J Trop Med Hyg. 1982;31:163-5. (PMID: 7036767)
53. 3Bruce-Chwatt LJ. Transfusion malaria revisited. Trop Dis Bull. 1982;79:827-40. (PMID: 6758249)
54. 3Chiche L, Lesage A, Duhamel C, Salame E, Malet M, Samba D, et al. Posttransplant malaria: first case of transmission of Plasmodium falciparum from a white multiorgan donor to four recipients [Letter]. Transplantation. 2003;75:166-8. (PMID: 12544892)
55. 1Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg. 2000;94 Suppl 1:S1-90. (PMID: 11103309)
56. 2O'Dempsey TJ, McArdle TF, Laurence BE, Lamont AC, Todd JE, Greenwood BM. Overlap in the clinical features of pneumonia and malaria in African children. Trans R Soc Trop Med Hyg. 1993;87:662-5. (PMID: 8296367)
57. 3Källander K, Nsungwa-Sabiiti J, Peterson S. Symptom overlap for malaria and pneumonia—policy implications for home management strategies. Acta Trop. 2004;90:211-4. (PMID: 15177148)
58. 3Carlini ME, White AC Jr, Atmar RL. Vivax malaria complicated by adult respiratory distress syndrome. Clin Infect Dis. 1999;28:1182-3. (PMID: 10452670)
59. 3Zingman BS, Viner BL. Splenic complications in malaria: case report and review. Clin Infect Dis. 1993;16:223-32. (PMID: 8443301)
60. 3Lawn SD, Krishna S, Jarvis JN, Joet T, Macallan DC. Case reports: pernicious complications of benign tertian malaria. Trans R Soc Trop Med Hyg. 2003;97:551-3. (PMID: 15307424)
61. 2McKenzie FE, Sirichaisinthop J, Miller RS, Gasser RA Jr, Wongsrichanalai C. Dependence of malaria detection and species diagnosis by microscopy on parasite density. Am J Trop Med Hyg. 2003;69:372-6. (PMID: 14640495)
62. 1Amexo M, Tolhurst R, Barnish G, Bates I. Malaria misdiagnosis: effects on the poor and vulnerable. Lancet. 2004;364:1896-8. (PMID: 15555670)
63. 3Bates I, Bekoe V, Asamoa-Adu A. Improving the accuracy of malaria-related laboratory tests in Ghana. Malar J. 2004;3:38. (PMID: 15516269)
64. 3Opoku-Okrah C, Rumble R, Bedu-Addo G, Bates I. Improving microscope quality is a good investment for under-resourced laboratories. Trans R Soc Trop Med Hyg. 2000;94:582. (PMID: 11132395)
65. 3Basic Malaria Microscopy. Part I: Learner's Guide. World Health Organization, Geneva, 1991.
66. 1Farcas GA, Zhong KJ, Lovegrove FE, Graham CM, Kain KC. Evaluation of the Binax NOW ICT test versus polymerase chain reaction and microscopy for the detection of malaria in returned travelers. Am J Trop Med Hyg. 2003;69:589-92. (PMID: 14740873)
67. 2De Monbrison F, Gérome P, Chaulet JF, Wallon M, Picot S, Peyron F. Comparative diagnostic performance of two commercial rapid tests for malaria in a non-endemic area. Eur J Clin Microbiol Infect Dis. 2004;23:784-6. (PMID: 15452770)
68. 2Humar A, Ohrt C, Harrington MA, Pillai D, Kain KC. Parasight F test compared with the polymerase chain reaction and microscopy for the diagnosis of Plasmodium falciparum malaria in travelers. Am J Trop Med Hyg. 1997;56:44-8. (PMID: 9063360)
69. 3Jelinek T, Grobusch MP, Nothdurft HD. Use of dipstick tests for the rapid diagnosis of malaria in nonimmune travelers. J Travel Med. 2000;7:175-9. (PMID: 11003728)
70. 1Palmer CJ, Bonilla JA, Bruckner DA, Barnett ED, Miller NS, Haseeb MA, et al. Multicenter study to evaluate the OptiMAL test for rapid diagnosis of malaria in U.S. hospitals. J Clin Microbiol. 2003;41:5178-82. (PMID: 14605156)
71. 1Moody A, Hunt-Cooke A, Gabbett E, Chiodini P. Performance of the OptiMAL malaria antigen capture dipstick for malaria diagnosis and treatment monitoring at the Hospital for Tropical Diseases, London. Br J Haematol. 2000;109:891-4. (PMID: 10929047)
72. 1Kolaczinski J, Mohammed N, Ali I, Ali M, Khan N, Ezard N, et al. Comparison of the OptiMAL rapid antigen test with field microscopy for the detection of Plasmodium vivax and P. falciparum: considerations for the application of the rapid test in Afghanistan. Ann Trop Med Parasitol. 2004;98:15-20. (PMID: 15000726)
73. 2Makler MT, Hinrichs DJ. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med Hyg. 1993;48:205-10. (PMID: 8447524)
74. 1Iqbal J, Khalid N, Hira PR. Performance of rapid malaria Pf antigen test for the diagnosis of malaria and false-reactivity with autoantibodies. Adv Exp Med Biol. 2003;531:135-48. (PMID: 12916786)
75. 2Erhart LM, Yingyuen K, Chuanak N, Buathong N, Laoboonchai A, Miller RS, et al. Hematologic and clinical indices of malaria in a semi-immune population of western Thailand. Am J Trop Med Hyg. 2004;70:8-14. (PMID: 14971691)
76. 2Looareesuwan S, Davis JG, Allen DL, Lee SH, Bunnag D, White NJ. Thrombocytopenia in malaria. Southeast Asian J Trop Med Public Health. 1992;23:44-50. (PMID: 1523477)
77. 2Patel U, Gandhi G, Friedman S, Niranjan S. Thrombocytopenia in malaria. J Natl Med Assoc. 2004;96:1212-4. (PMID: 15481750)
78. 2Evans JA, Adusei A, Timmann C, May J, Mack D, Agbenyega T, et al. High mortality of infant bacteraemia clinically indistinguishable from severe malaria. QJM. 2004;97:591-7. (PMID: 15317928)
79. 2Nguyen PH, Day N, Pram TD, Ferguson DJ, White NJ. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans R Soc Trop Med Hyg. 1995;89:200-4. (PMID: 7778149)
80. 2Milne LM, Kyi MS, Chiodini PL, Warhurst DC. Accuracy of routine laboratory diagnosis of malaria in the United Kingdom. J Clin Pathol. 1994;47:740-2. (PMID: 7962629)
81. 2Kain KC, Harrington MA, Tennyson S, Keystone JS. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis. 1998;27:142-9. (PMID: 9675468)
82. 2Hammerich A, Campbell OM, Chandramohan D. Unstable malaria transmission and maternal mortality—experiences from Rwanda. Trop Med Int Health. 2002;7:573-6. (PMID: 12100439)
83. 2Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet S, White NJ. The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg. 1997;91:256-62. (PMID: 9231189)
84. 2Muhlberger N, Jelinek T, Behrens RH, Gjorup I, Coulaud JP, Clerinx J, et al. Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin Infect Dis. 2003;36:990-5. (PMID: 12684911)
85. 2Bunn A, Escombe R, Armstrong M, Whitty CJ, Doherty JF. Falciparum malaria in malaria-naive travellers and African visitors. QJM. 2004;97:645-9. (PMID: 15367734)
86. 2Moore DA, Jennings RM, Doherty TF, Lockwood DN, Chiodini PL, Wright SG, et al. Assessing the severity of malaria. BMJ. 2003;326:808-9. (PMID: 12689980)
87. 2D'Acremont V, Landry P, Darioli R, Stuerchler D, Pecoud A, Genton B. Treatment of imported malaria in an ambulatory setting: prospective study. BMJ. 2002;324:875-7. (PMID: 11950734)
88. 3Deloron P, Chougnet C. Is immunity to malaria really short-lived? Parasitol Today. 1992;8:375-78.
89. 3Hamel CT, Blum J, Harder F, Kocher T. Nonoperative treatment of splenic rupture in malaria tropica: review of literature and case report. Acta Trop. 2002;82:1-5. (PMID: 11904097)
90. 3Oscherwitz SL. Chronic malaria with splenic rupture. J Travel Med. 2003;10:64-5. (PMID: 12729518)
91. 3Davies GR, Venkatesan P. Successful conservative management of splenic rupture in vivax malaria. Trans R Soc Trop Med Hyg. 2002;96:149-50. (PMID: 12055803)
92. 3Eiam-Ong S. Malarial nephropathy. Semin Nephrol. 2003;23:21-33. (PMID: 12563598)
93. 2Phillips RE, Looareesuwan S, White NJ, Chanthavanich P, Karbwang J, Supanaranond W, et al. Hypoglycaemia and antimalarial drugs: quinidine and release of insulin. Br Med J (Clin Res Ed). 1986;292:1319-21. (PMID: 3085830)
94. 2White NJ, Warrell DA, Chanthavanich P, Looareesuwan S, Warrell MJ, Krishna S, et al. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med. 1983;309:61-6. (PMID: 6343877)
95. 3Homewood CA. Transport of carbohydrates by malarial parasites. Bull World Health Organ. 1977;55:227. (PMID: 303948)
96. 3Phillips P, Nantel S, Benny WB. Exchange transfusion as an adjunct to the treatment of severe falciparum malaria: case report and review. Rev Infect Dis. 1990;12:1100-08. (PMID: 2267486)
97. 3Looareesuwan S, Phillips RE, Karbwang J, White NJ, Flegg PJ, Warrell DA. Plasmodium falciparum hyperparasitaemia: use of exchange transfusion in seven patients and a review of the literature. Q J Med. 1990;75:471-81. (PMID: 2201995)
98. 3Miller KD, Greenberg AE, Campbell CC. Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med. 1989;321:65-70. (PMID: 2659994)
99. 2Burchard GD, Kroger J, Knobloch J, Hartmann WJ, Eichenlaub D, Moling O, et al. Exchange blood transfusion in severe falciparum malaria: retrospective evaluation of 61 patients treated with, compared to 63 patients treated without, exchange transfusion. Trop Med Int Health. 1997;2:733-40. (PMID: 9294542)
100. 3Hoontrakoon S, Suputtamongkol Y. Exchange transfusion as an adjunct to the treatment of severe falciparum malaria. Trop Med Int Health. 1998;3:156-61. (PMID: 9537279)
101. 2Treatment of severe malaria by exchange transfusion. N Engl J Med. 1990;322:58-9. (PMID: 2403649)
102. 1Riddle MS, Jackson JL, Sanders JW, Blazes DL. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis. 2002;34:1192-8. (PMID: 11941545)
103. 3Molla S, de La Rubia J, Arriaga F, Fernandez MJ, Carpio N, Marty ML. Role of exchange transfusion in patients with severe Falciparum malaria: report of six cases. Haematologica. 2001;86:208-9. (PMID: 11224494)
104. 3Rego SJ, Subba Rao SD, Hejmadi A, Rekha S. Partial exchange transfusion as an adjunct to the treatment of severe falciparum malaria in children. J Trop Pediatr. 2001;47:118-9. (PMID: 11336130)
105. 1Looareesuwan S, Wilairatana P, Chalermarut K, Rattanapong Y, Canfield CJ, Hutchinson DB. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg. 1999;60:526-32. (PMID: 10348224)
106. 1Marquino W, Huilca M, Calampa C, Falconi E, Cabezas C, Naupay R, et al. Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru. Am J Trop Med Hyg. 2003;68:608-12. (PMID: 12812355)
107. 1de Alencar FE, Cerutti C Jr, Durlacher RR, Boulos M, Alves FP, Milhous W, et al. Atovaquone and proguanil for the treatment of malaria in Brazil. J Infect Dis. 1997;175:1544-7. (PMID: 9180204)
108. 1Fungladda W, Honrado ER, Thimasarn K, Kitayaporn D, Karbwang J, Kamolratanakul P, et al. Compliance with artesunate and quinine + tetracycline treatment of uncomplicated falciparum malaria in Thailand. Bull World Health Organ. 1998;76 Suppl 1:59-66. (PMID: 9763724)
109. 1McGready R, Cho T, Samuel, Villegas L, Brockman A, van Vugt M, et al. Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg. 2001;95:651-6. (PMID: 11816439)
110. 1Pukrittayakamee S, Chantra A, Vanijanonta S, Clemens R, Looareesuwan S, White NJ. Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria. Antimicrob Agents Chemother. 2000;44:2395-8. (PMID: 10952585)
111. 3Fivelman QL, Butcher GA, Adagu IS, Warhurst DC, Pasvol G. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Malar J. 2002;1:1. (PMID: 12057021)
112. 3Farnert A, Lindberg J, Gil P, Swedberg G, Berqvist Y, Thapar MM, et al. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports. BMJ. 2003;326:628-9. (PMID: 12649236)
113. 3Schwartz E, Bujanover S, Kain KC. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa. Clin Infect Dis. 2003;37:450-1. (PMID: 12884171)
114. 3Schwöbel B, Alifrangis M, Salanti A, Jelinek T. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker. Malar J. 2003;2:5. (PMID: 12665429)
115. 3Wichmann O, Muehlen M, Gruss H, Mockenhaupt FP, Suttorp N, Jelinek T. Malarone treatment failure not associated with previously described mutations in the cytochrome b gene. Malar J. 2004;3:14. (PMID: 15186499)
116. 1Driessen GJ, van Kerkhoven S, Schouwenberg BJ, Bonsu G, Verhave JP. Sulphadoxine/pyrimethamine: an appropriate first-line alternative for the treatment of uncomplicated falciparum malaria in Ghanaian children under 5 years of age. Trop Med Int Health. 2002;7:577-83. (PMID: 12100440)
117. 1Brasseur P, Guiguemde R, Diallo S, Guiyedi V, Kombila M, Ringwald P, et al. Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa. Trans R Soc Trop Med Hyg. 1999;93:645-50. (PMID: 10717757)
118. 1Olliaro P, Nevill C, LeBras J, Ringwald P, Mussano P, Garner P, et al. Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet. 1996;348:1196-201. (PMID: 8898036)
119. 1Olliaro P, Mussano P. Amodiaquine for treating malaria. Cochrane Database Syst Rev. 2003;(2):CD000016. (PMID: 12804382)
120. 3Treatment of severe Plasmodium falciparum malaria with quinidine gluconate: discontinuation of parenteral quinine from CDC drug service. MMWR Morb Mortal Wkly Rep. 1991;40:240. (PMID: 1848916)
121. 3Availability and use of parenteral quinidine gluconate for severe or complicated malaria. MMWR Morb Mortal Wkly Rep. 2000;49:1138-40. (PMID: 11190119)
122. 3Humar A, Sharma S, Zoutman D, Kain KC. Fatal falciparum malaria in Canadian travellers. CMAJ. 1997;156:1165-7. (PMID: 9141989)
123. 2White NJ, Looareesuwan S, Warrell DA, Warrell MJ, Bunnag D, Harinasuta T. Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria. Am J Med. 1982;73:564-72. (PMID: 6751085)
124. 3Bhavnani SM, Preston SL. Monitoring of intravenous quinidine infusion in the treatment of Plasmodium falciparum malaria. Ann Pharmacother. 1995;29:33-5. (PMID: 7711344)
125. 1Lell B, Kremsner PG. Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob Agents Chemother. 2002;46:2315-20. (PMID: 12121898)
126. 2Berkley J, Mwarumba S, Bramham K, Lowe B, Marsh K. Bacteraemia complicating severe malaria in children. Trans R Soc Trop Med Hyg. 1999;93:283-6. (PMID: 10492760)
127. 3van Agtmael MA, Eggelte TA, van Boxtel CJ. Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol Sci. 1999;20:199-205. (PMID: 10354615)
128. 3Price R, van Vugt M, Phaipun L, Luxemburger C, Simpson J, McGready R, et al. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg. 1999;60:547-55. (PMID: 10348227)
129. 1McGready R, Brockman A, Cho T, Cho D, van Vugt M, Luxemburger C, et al. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg. 2000;94:689-93. (PMID: 11198658)
130. 1McIntosh HM, Olliaro P. Artemisinin derivatives for treating severe malaria. Cochrane Database Syst Rev. 2000;(2):CD000527. (PMID: 10796551)
131. 1Arnold K, Tran TH, Nguyen TC, Nguyen HP, Pham P. A randomized comparative study of artemisinine (qinghaosu) suppositories and oral quinine in acute falciparum malaria. Trans R Soc Trop Med Hyg. 1990;84:499-502. (PMID: 2091337)
132. 1Hien TT, Arnold K, Vinh H, Cuong BM, Phu NH, Chau TT, et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg. 1992;86:582-3. (PMID: 1287904)
133. 1Barnes KI, Mwenechanya J, Tembo M, McIlleron H, Folb PI, Ribeiro I, et al. Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study. Lancet. 2004;363:1598-605. (PMID: 15145633)
134. 2Smoak BL, DeFraites RF, Magill AJ, Kain KC, Wellde BT. Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia. Am J Trop Med Hyg. 1997;56:231-4. (PMID: 9080885)
135. 1Gogtay NJ, Desai S, Kamtekar KD, Kadam VS, Dalvi SS, Kshirsagar NA. Efficacies of 5- and 14-day primaquine regimens in the prevention of relapses in Plasmodium vivax infections. Ann Trop Med Parasitol. 1999;93:809-12. (PMID: 10715673)
136. 2Buchachart K, Krudsood S, Singhasivanon P, Treeprasertsuk S, Phophak N, Srivilairit S, et al. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand. Southeast Asian J Trop Med Public Health. 2001;32:720-6. (PMID: 12041544)
137. 3Doherty JF, Day JH, Warhurst DC, Chiodini PL. Treatment of Plasmodium vivax malaria—time for a change? Trans R Soc Trop Med Hyg. 1997;91:76. (PMID: 9093635)
138. 1Bunnag D, Karbwang J, Thanavibul A, Chittamas S, Ratanapongse Y, Chalermrut K, et al. High dose of primaquine in primaquine resistant vivax malaria. Trans R Soc Trop Med Hyg. 1994;88:218-9. (PMID: 8036680)
139. 1Wilairatana P, Silachamroon U, Krudsood S, Singhasivanon P, Treeprasertsuk S, Bussaratid V, et al. Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand. Am J Trop Med Hyg. 1999;61:973-7. (PMID: 10674681)
140. 2Collins WE, Jeffery GM. Primaquine resistance in Plasmodium vivax. Am J Trop Med Hyg. 1996;55:243-9. (PMID: 8842108)
141. 3The Use of Antimalarial Drugs: Report of an Informal Consultation. Geneva; World Health Organization: 2001. [Full Text]
142. 1Rowland M, Durrani N. Randomized controlled trials of 5- and 14-days primaquine therapy against relapses of vivax malaria in an Afghan refugee settlement in Pakistan. Trans R Soc Trop Med Hyg. 1999;93:641-3. (PMID: 10717755)
143. 3Shanks GD, Kain KC, Keystone JS. Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future. Clin Infect Dis. 2001;33:381-5. (PMID: 11438908)
144. 3Emberger M, Lechner AM, Zelger B. Stevens-Johnson syndrome associated with Malarone antimalarial prophylaxis. Clin Infect Dis. 2003;37:e5-7. (PMID: 12830430)
145. 3Hamer DH, Connor BA. Travel health knowledge, attitudes and practices among United States travelers. J Travel Med. 2004;11:23-6. (PMID: 14769283)
146. 3Basco LK. Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. Am J Trop Med Hyg. 2004;70:245-50. (PMID: 15031511)
147. 1Nothdurft HD, Jelinek T, Pechel SM, Hess F, Maiwald H, Marschang A, et al. Stand-by treatment of suspected malaria in travellers. Trop Med Parasitol. 1995;46:161-3. (PMID: 8533018)
148. 3Malaria in travelers returning from Kenya: failure of self-treatment with pyrimethamine/sulfadoxine. MMWR Morb Mortal Wkly Rep. 1989;38:363-4. (PMID: 2497333)
149. 3Atovaquone/proguanil (Malarone) for malaria. Med Lett. 2000;42(1093):109-11.
150. 1Bindschedler M, Lefèvre G, Degen P, Sioufi A. Comparison of the cardiac effects of the antimalarials co-artemether and halofantrine in healthy participants. Am J Trop Med Hyg. 2002;66:293-8. (PMID: 12139223)
151. 2Bruneel F, Hocqueloux L, Alberti C, Wolff M, Chevret S, Bedos JP, et al. The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults. Am J Respir Crit Care Med. 2003;167:684-9. (PMID: 12411286)
152. 2Moore TA, Tomayko JF Jr, Wierman AM, Rensimer ER, White AC Jr. Imported malaria in the 1990s. A report of 59 cases from Houston, Tex. Arch Fam Med. 1994;3:130-6. (PMID: 7994434)
153. 1Smithuis FM, van Woensel JB, Nordlander E, Vantha WS, ter Kuile FO. Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border. Antimicrob Agents Chemother. 1993;37:1977-81. (PMID: 8239616)
154. 3White NJ. The assessment of antimalarial drug efficacy. Trends Parasitol. 2002;18:458-64. (PMID: 12377597)
155. 1Cot M, Roisin A, Barro D, Yada A, Verhave JP, Carnevale P, et al. Effect of chloroquine chemoprophylaxis during pregnancy on birth weight: results of a randomized trial. Am J Trop Med Hyg. 1992;46:21-7. (PMID: 1536379)
156. 2Boudreau E, Schuster B, Sanchez J, Novakowski W, Johnson R, Redmond D, et al. Tolerability of prophylactic Lariam regimens. Trop Med Parasitol. 1993;44:257-65. (PMID: 8256107)
157. 2Weinke T, Trautmann M, Held T, Weber G, Eichenlaub D, Fleischer K, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg. 1991;45:86-91. (PMID: 1867351)
158. 2Vanhauwere B, Maradit H, Kerr L. Postmarketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy. Am J Trop Med Hyg. 1998;58:17-21. (PMID: 9452285)
159. 2Smoak BL, Writer JV, Keep LW, Cowan J, Chantelois JL. The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcomes and infants of US Army servicewomen. J Infect Dis. 1997;176:831-3. (PMID: 9291347)
160. 1Nosten F, ter Kuile F, Maelankiri L, Chongsuphajaisiddhi T, Nopdonrattakoon L, Tangkitchot S, et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. J Infect Dis. 1994;169:595-603. (PMID: 8158032)
161. 2Phillips-Howard PA, Steffen R, Kerr L, Vanhauwere B, Schildknecht J, Fuchs E, et al. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. J Travel Med. 1998;5:121-6. (PMID: 9772329)
162. 3Bradley DJ, Warhurst DC. Guidelines for the prevention of malaria in travellers from the United Kingdom. PHLS Malaria Reference Laboratory, London School of Hygiene and Tropical Medicine. Commun Dis Rep CDR Rev. 1997;7:R137-52. (PMID: 9376899)
163. 2Wallace MR, Sharp TW, Smoak B, Iriye C, Rozmajzl P, Thornton SA, et al. Malaria among United States troops in Somalia. Am J Med. 1996;100:49-55. (PMID: 8579087)
New References of Interest
164. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455-67. (PMID: 19641202)
165. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, et al. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med. 2009;361:468-77. (PMID: 19641203)
166. Achan J, Tibenderana JK, Kyabayinze D, Wabwire Mangen F, Kamya MR, Dorsey G, et al. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. BMJ. 2009;339:b2763. (PMID: 19622553)
167. Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M, et al. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:1521-32. (PMID: 19765815)
168. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, et al. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet. 2009;374:1533-42. (PMID: 19765816)
FAQs
Harry Tagbor, MBChB, DrPH, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Rick M. Fairhurst, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Thomas E. Wellems, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.